top of page

What is Sodium Valproate

valproate semi sodium epilim dyzantil syonell depakote epival

Introduction

​

Sodium Valproate is a medicine primarily used to treat epilepsy, bipolar disorder, and, in some cases, migraine prevention. It has been prescribed worldwide for decades and is recognised for its effectiveness in controlling certain types of seizures, particularly generalised epilepsies. In the United Kingdom, sodium valproate is commonly known by the brand name Epilim.

​For many people, sodium valproate has been a life-changing medication, helping to reduce seizure frequency and improve quality of life. However, increasing awareness over recent decades has also highlighted significant safety concerns associated with its use,  particularly during pregnancy and in long-term

​

 

​How Sodium Valproate Works

Sodium valproate works by affecting chemical signalling in the brain. It increases levels of gamma-aminobutyric acid (GABA), a neurotransmitter that helps calm excessive electrical activity. By stabilising these signals, sodium valproate can help prevent seizures and regulate abnormal brain activity.

Because epilepsy is a complex condition with many different seizure types, sodium valproate may be highly effective for some individuals when other medications are less successful.

​

Uses of Sodium Valproate

​

Sodium valproate may be prescribed for:

  • Epilepsy and seizure disorders

  • Generalised epilepsy syndromes

  • Bipolar disorder

  • Migraine prevention

  • Certain neurological conditions

​​

Treatment decisions are often based on balancing seizure control with potential risks and side effects.

​

Side Effects and Long-Term Concerns

​

Like many medicines, sodium valproate can cause side effects. Some may be mild, while others can become more serious over time.

Reported side effects may include:

​

  • Fatigue and drowsiness

  • Weight gain

  • Tremor

  • Hair thinning

  • Digestive problems

  • Hormonal and reproductive disturbances

  • Cognitive or memory difficulties

  • Liver and pancreatic complications

  • Bone health concerns

  • Metabolic changes

​​

Some patients and families have also raised concerns regarding long-term neurological, endocrine, mitochondrial, and systemic health effects associated with prolonged exposure or complex medicine interactions.

episenta depakote convulex belvo orlept depakene

Sodium Valproate and Pregnancy

​

The most widely recognised concern surrounding sodium valproate is its teratogenic risk during pregnancy. Exposure during pregnancy can increase the risk of congenital malformations and developmental difficulties in children.

​

These risks may include:

​

  • Neural tube defects such as spina bifida

  • Heart defects

  • Limb and facial abnormalities

  • Developmental delay

  • Autism spectrum disorder

  • Speech and language difficulties

 

  • Learning disabilities

  • Attention and behavioural difficulties

​​

Because of these risks, strict pregnancy prevention programmes and prescribing guidance have been introduced in many countries. Women and girls of childbearing potential prescribed sodium valproate are now advised to receive detailed counselling regarding the potential risks and available alternatives where appropriate.

​

The Importance of Shared Decision Making

​

The use of sodium valproate highlights the importance of informed consent and shared decision-making in medicine. For some individuals, sodium valproate may remain the most effective treatment available, particularly where uncontrolled seizures themselves pose serious risks.

​

Every treatment decision should involve careful discussion between patients, families, and healthcare professionals, considering:

​

  • The severity of epilepsy

  • The effectiveness of alternative medications

  • Pregnancy considerations

  • Quality of life

  • Physical and mental health impacts

  • Long-term safety monitoring

Patients and families should feel supported in asking questions, discussing concerns, and reviewing treatment regularly.

​

Ongoing Research and Awareness

Research into sodium valproate continues to evolve. Scientists, clinicians, regulators, and patient advocacy groups are working to better understand:

  • Long-term health outcomes

  • Mechanisms of teratogenicity

  • Genetic and epigenetic factors

  • Neurodevelopmental effects

  • Safer prescribing practices

  • Improved patient support and monitoring#

​​

The experiences of affected individuals and families have played an important role in raising awareness and encouraging improvements in medical safety and informed consent.

​

Conclusion

​

Sodium valproate remains an important medication in neurological care, particularly in epilepsy treatment. However, its history also reflects the complexity of balancing medical benefit with potential harm. Understanding both its therapeutic value and its risks is essential for safe, compassionate, and informed healthcare.

Ongoing education, research, patient involvement, and careful monitoring remain vital in improving outcomes for current and future generations.

bottom of page